Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy

被引:18
作者
Wang, Zheng-Xia [1 ,2 ,3 ]
Peng, Wei [1 ,2 ]
Zhang, Xiao-Yun [1 ,2 ]
Wen, Tian-Fu [1 ,2 ]
Li, Chuan [1 ,2 ]
机构
[1] Sichuan Univ, Dept Liver Surg, West China Hosp, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Liver Transplantat Ctr, West China Hosp, Chengdu 610041, Peoples R China
[3] Chengdu Second Peoples Hosp, Dept Hepatobiliary Pancreat Surg, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatectomy; hepatocellular carcinoma; nomogram; PALBI grade; prognosis; LIVER RESECTION; RISK-FACTORS; RECURRENCE; ALBI; HCC; PLATELETS; SURVIVAL; ALBUMIN;
D O I
10.1097/MD.0000000000024476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The platelet-albumin-bilirubin (PALBI) grade plays critical role in evaluating liver function. However, the change of PALBI grade from the preoperative to postoperative period in predicting patient outcomes after hepatectomy remains unclear. A total of 489 HCC patients who underwent hepatectomy in West China Hospital between January, 2010 and June, 2016 were analyzed retrospectively.Delta PALBI grade was calculated by PALBI grade at the first postoperative month - preoperative PALBI grade.Delta PALBI >0 was considered as stable; otherwise, worse PALBI grade was considered. Kaplan- Meier method and Cox proportional hazard regression analyses were performed for survival analysis. Prognostic model was constructed by nomogram method. Three hundred forty two patients and 147 patients were classified into training group and validation group, respectively. In the training group, results from Cox model suggested that worse PALBI grade (HR 1.328, 95% CI 1.010-1.746, P = .042), tumor size (HR 1.460, 95% CI 1.058-2.015, P = .021), microvascular invasion (MVI, HR 1.802, 95% CI 1.205-2.695, P < .001), and high alpha-fetoprotein level (AFP, HR 1.364, 95% CI 1.044-1.781, P = .023) negatively influenced postoperative recurrence. Similarly, worse PALBI grade (HR 1.403, 95% CI 1.020-1.930, P = .038), tumor size (HR 1.708, 95% CI 1.157-2.520, P = .007), MVI (HR 1.914, 95% CI 1.375-2.663, P < .001), and presence of cirrhosis (HR 1.773, 95% CI 1.226-2.564, P = .002) had negatively impacts on overall survival. Patients with worse PALBI grade had worse recurrence free (RFS) and overall survival (OS). The prognostic model incorporating the change of PALBI grade constructed in training group and tested in the validation group could perform well in predicting the outcomes. Postoperative change of PALBI grade was independently risk factor related with prognosis. Prognostic model incorporating the change of PALBI grade might be a useful index to predict the prognosis of HCC patients following hepatectomy.
引用
收藏
页数:9
相关论文
共 33 条
[1]   Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma [J].
Bagirsakci, Ezgi ;
Sahin, Eren ;
Atabey, Nese ;
Erdal, Esra ;
Guerra, Vito ;
Carr, Brian I. .
ONCOLOGY, 2017, 93 (02) :136-142
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Validating the ALBI grade: Its current and future use in HCC prognostication [J].
Chan, Anthony W. H. ;
Leung, Howard H. W. ;
Chong, Charing C. N. ;
Chan, Stephen L. .
JOURNAL OF HEPATOLOGY, 2017, 66 (03) :661-663
[4]  
Chan AW., 2016, J GASTROEN HEPATOL, DOI [10.1111/jgh.1329, DOI 10.1111/JGH.1329]
[5]   Platelets: No longer bystanders in liver disease [J].
Chauhan, Abhishek ;
Adams, David H. ;
Watson, Steve P. ;
Lalor, Patricia F. .
HEPATOLOGY, 2016, 64 (05) :1774-1784
[6]  
Cheng YC, 2014, ANN TRANSPL, V19, P309, DOI 10.12659/AOT.890505
[7]  
Child C G, 1964, Major Probl Clin Surg, V1, P1
[8]   Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD [J].
Durand, F ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2005, 42 :S100-S107
[9]   Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma [J].
Farinati, Fabio ;
Vitale, Alessandro ;
Spolverato, Gaya ;
Pawlik, Timothy M. ;
Huo, Teh-la ;
Lee, Yun-Hsuan ;
Frigo, Anna Chiara ;
Giacomin, Anna ;
Giannini, Edoardo G. ;
Ciccarese, Francesca ;
Piscaglia, Fabio ;
Rapaccini, Gian Lodovico ;
Di Marco, Mariella ;
Caturelli, Eugenio ;
Zoli, Marco ;
Borzio, Franco ;
Cabibbo, Giuseppe ;
Felder, Martina ;
Sacco, Rodolfo ;
Morisco, Filomena ;
Biasini, Elisabetta ;
Foschi, Francesco Giuseppe ;
Gasbarrini, Antonio ;
Baroni, Gianluca Svegliati ;
Virdone, Roberto ;
Masotto, Alberto ;
Trevisani, Franco ;
Cillo, Umberto .
PLOS MEDICINE, 2016, 13 (04)
[10]   Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model [J].
Fox, R. ;
Berhane, S. ;
Teng, M. ;
Cox, T. ;
Tada, T. ;
Toyoda, H. ;
Kumada, T. ;
Kagebayashi, C. ;
Satomura, S. ;
Johnson, P. J. .
BRITISH JOURNAL OF CANCER, 2014, 110 (08) :2090-2098